Effect of Different Classes of Gadolinium-based Contrast Agents on Control and Nephrogenic Systemic Fibrosis–derived Fibroblast Proliferation
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Different Classes of Gadolinium-based Contrast Agents on Control and Nephrogenic Systemic Fibrosis–derived Fibroblast Proliferation
Authors
Keywords
-
Journal
RADIOLOGY
Volume 256, Issue 3, Pages 735-743
Publisher
Radiological Society of North America (RSNA)
Online
2010-07-28
DOI
10.1148/radiol.10091131
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C
- (2010) Thomas Frenzel et al. INVESTIGATIVE RADIOLOGY
- Induction of the expression of profibrotic cytokines and growth factors in normal human peripheral blood monocytes by gadolinium contrast agents
- (2009) Peter J. Wermuth et al. ARTHRITIS AND RHEUMATISM
- High Prevalence of Nephrogenic Systemic Fibrosis in Chronic Renal Failure Patients Exposed to Gadodiamide, a Gadolinium-Containing Magnetic Resonance Contrast Agent
- (2009) Casper Rydahl et al. INVESTIGATIVE RADIOLOGY
- Effects of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents on Human Skin in Organ Culture and Human Skin Fibroblasts
- (2009) James Varani et al. INVESTIGATIVE RADIOLOGY
- Collagenolytic Activity Is Suppressed in Organ-Cultured Human Skin Exposed to a Gadolinium-Based MRI Contrast Agent
- (2009) Patricia A. Perone et al. INVESTIGATIVE RADIOLOGY
- Mechanism of NSF: New evidence challenging the prevailing theory
- (2009) Ben B. Newton et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- NSF after Gadovist exposure: a case report and hypothesis of NSF development
- (2009) H. Wollanka et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Nephrogenic Systemic Fibrosis after Gadopentetate Dimeglumine Exposure: Case Series of 36 Patients
- (2009) Hani H. Abujudeh et al. RADIOLOGY
- Imatinib mesylate treatment of nephrogenic systemic fibrosis
- (2008) Jonathan Kay et al. ARTHRITIS AND RHEUMATISM
- Chronic inflammation and accelerated atherosclerosis as important cofactors in nephrogenic systemic fibrosis following intravenous gadolinium exposure
- (2008) Scott O. Grebe et al. Clinical and Experimental Nephrology
- Risk for Nephrogenic Systemic Fibrosis with Gadoteridol (ProHance) in Patients Who Are on Long-Term Hemodialysis
- (2008) R. F. Reilly Clinical Journal of the American Society of Nephrology
- Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis
- (2008) Jerrold L. Abraham et al. EUROPEAN JOURNAL OF RADIOLOGY
- Clinical and histological findings in nephrogenic systemic fibrosis
- (2008) Shawn E. Cowper et al. EUROPEAN JOURNAL OF RADIOLOGY
- Extracellular gadolinium contrast agents: Differences in stability
- (2008) S.K. Morcos EUROPEAN JOURNAL OF RADIOLOGY
- Gadodiamide contrast agent ‘activates’ fibroblasts: a possible cause of nephrogenic systemic fibrosis
- (2008) M Edward et al. JOURNAL OF PATHOLOGY
- Incidence of Nephrogenic Systemic Fibrosis at Two Large Medical Centers
- (2008) Martin R. Prince et al. RADIOLOGY
- Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: A critical review
- (2008) Jean-Marc Idée et al. TOXICOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started